Remission Medical Raises Funding to Expand Virtual Rheumatology Platform for Health Systems

Rheumatology is one of those corners of healthcare where time drags and outcomes follow. Demand stacks up, specialists stay scarce, and patients end up negotiating with the calendar instead of getting care. That gap is not theoretical. It is operational. Blake Wehman, CEO, lived it, studied it, and then decided to build something that does not wait around for the system to fix itself.

Remission Medical just pulled in $5M in Series A funding, led by Blue Heron Capital, and the signal here is louder than the number. This is a Richmond-born company, grounded in lived experience and sharpened inside health systems, now scaling a model that meets providers where they already operate. Not another shiny layer on top. This one plugs straight into the bloodstream.

Blake Wehman, CEO, took an operations mindset and paired it with a personal story that does not need dramatics to land. The result is a virtual-first rheumatology platform that embeds directly into health systems, using their workflows, their EMRs, their contracts. Translation: no extra friction, no theatrical handoffs, just more capacity where there was none. Tyler Beard, CTO, is the one making sure that engine runs clean, with RemissionOS quietly coordinating the moving parts behind the curtain.

And that is where it gets interesting. This is not telehealth dressed up for headlines. This is a workforce model, tuned for reality. Advanced practice providers, supervised by board-certified rheumatologists, deployed with precision. Patient-reported outcomes feeding the system. Generative intelligence shaping care pathways without trying to steal the spotlight. It is less about replacing doctors and more about extending them, which is exactly what the market has been begging for.

Blue Heron Capital stepping in as lead tells you this is not a science project. It is a bet on execution. No inflated promises, no mystery metrics, just a clear read on a broken supply-demand curve and a team that knows how to bend it back into shape.

Dr. Kyle Harner, CMO, bringing 20+ years of clinical depth. Blake Siewert, CRO, pushing revenue with intention. Michael Spine, Chief Growth Officer, driving partnerships where they actually convert. Matt Hogan, VP of Business Development, building the bridges that make health systems say yes instead of maybe. It is a lineup that understands that access is not an idea, it is logistics.

The quiet part that should not stay quiet is this: embedding beats overlaying. Health systems do not need more tabs open. They need throughput, outcomes, and something that respects how care actually gets delivered.